28 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Aug 23
Maravai Lifesciences Reports Second Quarter 2023 Financial Results
4:19pm
to serve as Executive Chair of the Board of Directors;
Appointed medical technology expert Dr. John DeFord to the Board of Directors;
Took occupancy
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
associated with that role. Dr. DeFord, a medical technology expert, was appointed to fill the vacancy.
Dr. DeFord is the Chairman, Chief Executive Officer
8-K
EX-10.1
pqsqho794v5uh
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-3.2
ivjdq86k
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.2
0o1tmaw1lsrgcuyy
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.3
4m1s8aopm5b
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
rf0236ic3pnmh 7c
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1/A
EX-10.12
mm92fm
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.9
3kko2da42
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.10
3m4zm 7wqzq
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.8
vj6d njwx
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-3.2
rzfi4
9 Nov 20
IPO registration (amended)
2:05pm
S-1
EX-10.23
zrfl0uzyh6xd87h08zs
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.22
kwxqp0i
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.21
bobjlpo237pks r7ebe2
29 Oct 20
IPO registration
5:04pm
S-1
bc7vly6v
29 Oct 20
IPO registration
5:04pm